These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21554876)

  • 1. Combination of CpG-oligodeoxynucleotides with recombinant ROP2 or GRA4 proteins induces protective immunity against Toxoplasma gondii infection.
    Sánchez VR; Pitkowski MN; Fernández Cuppari AV; Rodríguez FM; Fenoy IM; Frank FM; Goldman A; Corral RS; Martin V
    Exp Parasitol; 2011 Aug; 128(4):448-53. PubMed ID: 21554876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2009 Sep; 123(1):81-9. PubMed ID: 19508869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes.
    Li B; Oledzka G; McFarlane RG; Spellerberg MB; Smith SM; Gelder FB; Kur J; Stankiewicz M
    Parasite Immunol; 2010; 32(9-10):671-83. PubMed ID: 20691019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
    Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG-oligodeoxynucleotides enhance porcine immunity to Toxoplasma gondii.
    Kringel H; Dubey JP; Beshah E; Hecker R; Urban JF
    Vet Parasitol; 2004 Aug; 123(1-2):55-66. PubMed ID: 15265571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
    Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
    Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
    Xue M; He S; Cui Y; Yao Y; Wang H
    Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii.
    Jongert E; de Craeye S; Dewit J; Huygen K
    Parasite Immunol; 2007 Sep; 29(9):445-53. PubMed ID: 17727568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.
    Golkar M; Shokrgozar MA; Rafati S; Musset K; Assmar M; Sadaie R; Cesbron-Delauw MF; Mercier C
    Vaccine; 2007 May; 25(21):4301-11. PubMed ID: 17418457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine potential of antigen cocktails composed of recombinant Toxoplasma gondii TgPI-1, ROP2 and GRA4 proteins against chronic toxoplasmosis in C3H mice.
    Picchio MS; Sánchez VR; Arcon N; Soto AS; Perrone Sibilia M; Aldirico MLA; Urrutia M; Moretta R; Fenoy IM; Goldman A; Martin V
    Exp Parasitol; 2018 Feb; 185():62-70. PubMed ID: 29309783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein.
    Echeverria PC; de Miguel N; Costas M; Angel SO
    Vaccine; 2006 May; 24(19):4102-10. PubMed ID: 16545504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the immuno-protection of ROP2 nuclei acid vaccine in Toxoplasma gondii infection].
    Wei QK; Li J; Fu TX; Bai XL; Cui Y; Zhang DB; Wang HF; Liu YB; Fu B; Zai DF; Huang BC; Liu KY; Han GD
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Oct; 24(5):337-41. PubMed ID: 17361811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice.
    Zhang G; Huong VT; Battur B; Zhou J; Zhang H; Liao M; Kawase O; Lee EG; Dautu G; Igarashi M; Nishikawa Y; Xuan X
    Parasitology; 2007 Sep; 134(Pt 10):1339-46. PubMed ID: 17506929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen.
    Tewary P; Sukumaran B; Saxena S; Madhubala R
    Vaccine; 2004 Aug; 22(23-24):3053-60. PubMed ID: 15297055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG-containing ODN has a limited role in the protection against Toxoplasma gondii.
    Saavedra R; Leyva R; Tenorio EP; Haces ML; Rodríguez-Sosa M; Terrazas LI; Hérion P
    Parasite Immunol; 2004 Feb; 26(2):67-73. PubMed ID: 15225293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune response elicited by the recombinant protein and plasmid DNA of complex antigen ROP2-SAG1 from Toxoplasma gondii].
    Li WS; Xie ZX; Chen QX; Chen S; Zhang LF
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Oct; 28(5):359-63. PubMed ID: 21351549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis.
    Martin V; Supanitsky A; Echeverria PC; Litwin S; Tanos T; De Roodt AR; Guarnera EA; Angel SO
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):704-10. PubMed ID: 15242945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection.
    Tewary P; Pandya J; Mehta J; Sukumaran B; Madhubala R
    FEMS Immunol Med Microbiol; 2004 Oct; 42(2):241-8. PubMed ID: 15364110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cholera toxin A2/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine.
    Xue M; He S; Zhang J; Cui Y; Yao Y; Wang H
    Exp Parasitol; 2008 Jul; 119(3):352-7. PubMed ID: 18442818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.